Posts

FDA Issues Warning Letter to J&J Subsidiary Over Stopper Issues and Quality Reporting at Korean Plant

on

Eli Lilly Picks Houston for $6.5 Billion API Manufacturing Facility

on

FDA Delays Decision on Sanofi's Oral Multiple Sclerosis Drug to December 2025

on

Parkinson’s Patients Prefer Medtronic’s Adaptive Brain Stimulation Over Traditional Settings, Major Study Shows

on

FDA Grants Accelerated Approval to Stealth BioTherapeutics’ Forzinity, the First Treatment for Barth Syndrome

on

BMS Breaks Clinical Losing Streak with Positive Phase 3 Myeloma Readout for Iberdomide

on

Seres Therapeutics Cuts 25% of Workforce Following FDA Feedback on Microbiome Therapy Trial

on

FDA Rejects Scholar Rock's SMA Drug Due to Catalent Indiana Manufacturing Issues

on

FDA Rejects Lundbeck and Otsuka's Rexulti for PTSD on Insufficient Efficacy Evidence

on

Roche’s Top Three Ambition in Obesity Not Dependent on a Single Megablockbuster

on

Celltrion Acquires Eli Lilly’s New Jersey Manufacturing Site for $330 Million

on

Fierce Biotech Fundraising Tracker '25: Avenzo adds $60M Series B; Ollin debuts with $100M

on

Roche's Oral SERD Achieves Progression-Free Survival Milestone in Pivotal Breast Cancer Trial

on